These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 3185065)

  • 21. [Immunological problems in oncology (author's transl)].
    Petruzzelli C; Comotti F; Pugnani M; Sacchi L; Cereser M
    Ann Sclavo; 1979; 21(4):502-44. PubMed ID: 95475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human monoclonal antibodies.
    Kan-Mitchell J; Mitchell MS
    Prog Clin Biol Res; 1989; 288():85-94. PubMed ID: 2717643
    [No Abstract]   [Full Text] [Related]  

  • 23. [Monoclonal antibodies and cancer].
    López González JS; Selman Lama M
    Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157
    [No Abstract]   [Full Text] [Related]  

  • 24. A highly restricted antigen for renal cell carcinoma defined by a monoclonal antibody.
    Moon TD; Vessella RL; Palme DF; Nowak JA; Lange PH
    Hybridoma; 1985; 4(2):163-71. PubMed ID: 3891589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
    Wilson BS; Petrella E; Lowe SR; Lien K; Mackensen DG; Gridley DS; Stickney DR
    Cancer Res; 1990 May; 50(10):3124-30. PubMed ID: 2159374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antigens and antigenic systems].
    Cordón-Cardo C; Graus F
    Med Clin (Barc); 1987 Mar; 88(9):381-7. PubMed ID: 3553765
    [No Abstract]   [Full Text] [Related]  

  • 27. Secondary antibodies as tools to improve tumor to non tumor ratio at radioimmunolocalisation and radioimmunotherapy.
    Ullén A; Ahlström KR; Heitala S; Nilsson B; Arlestig L; Stigbrand T
    Acta Oncol; 1996; 35(3):281-5. PubMed ID: 8679257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Monoclonal antibodies in the radionuclide diagnosis and therapy of tumors].
    Anokhin IuN; Dedenkov AN; Norets TA
    Med Radiol (Mosk); 1985 Jun; 30(6):72-8. PubMed ID: 3894856
    [No Abstract]   [Full Text] [Related]  

  • 29. The immunoreactivity of radiolabeled antibodies--its impact on tumor targeting and strategies for preservation.
    Reilly R
    Cancer Biother Radiopharm; 2004 Dec; 19(6):669-72. PubMed ID: 15665615
    [No Abstract]   [Full Text] [Related]  

  • 30. Monoclonal antibody therapy for cancer.
    Lovett DR; Scheinberg DA; Houghton AN
    Cancer Chemother Biol Response Modif; 1991; 12():147-63. PubMed ID: 1931442
    [No Abstract]   [Full Text] [Related]  

  • 31. [Natural cytotoxic cells (NK) and their role in the immunological control of neoplasms].
    Rupniewska ZM; Adamczyk MB
    Postepy Hig Med Dosw; 1981; 35(1):37-52. PubMed ID: 6174960
    [No Abstract]   [Full Text] [Related]  

  • 32. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiolabelled monoclonal antibodies in oncology. II. Clinical applications in diagnosis.
    Granowska M; Britton KE
    Nucl Med Commun; 1991 Feb; 12(2):83-98. PubMed ID: 2002966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A monoclonal antibody produced against the surface immunoglobulin of B-prolymphocytic leukemia].
    López Nevot MA; Ruiz-Cabello F; Huelin C; Cabrera A; Garrido F
    Sangre (Barc); 1986; 31(6):751-8. PubMed ID: 3551142
    [No Abstract]   [Full Text] [Related]  

  • 35. [The evaluation of the efficiency in the detection of embryonal cancer and tumor-related antigens as tumor markers in gastrointestinal cancer].
    Cheshenko VP
    Klin Khir; 1998; (5):20-1. PubMed ID: 9787561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential clinical utility of monoclonal antibodies in the management of human carcinomas.
    Schlom J; Weeks MO
    Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739
    [No Abstract]   [Full Text] [Related]  

  • 37. Mechanisms of immunity in cancer.
    Baldwin RW
    Pathobiol Annu; 1981; 11():155-75. PubMed ID: 6460216
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of antibodies against tumor-associated antigens for cancer diagnosis and treatment.
    Ghose T; Ramakrishnan S; Kulkarni P; Blair AH; Vaughan K; Nolido H; Norvell ST; Belitsky P
    Transplant Proc; 1981 Dec; 13(4):1970-2. PubMed ID: 7330980
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new monoclonal antibody produced against a human leukemia which recognizes class II HLA antigens].
    Ruiz-Cabello F; González M; López MA; Cabrera A; San Miguel J; Garrido F
    Sangre (Barc); 1985; 30(2):190-6. PubMed ID: 3859940
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.